Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $314

Author: Benzinga Newsdesk | October 23, 2025 01:58pm

Morgan Stanley analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $312 to $314.

Posted In: CME